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Abstract
Background: National diabetes audits in the UK show room for improvement in the quality of care delivered to
people with type 2 diabetes in primary care. Systematic reviews of quality improvement interventions show that
such approaches can be effective but there is wide variability between trials and little understanding concerning
what explains this variability. A national cohort study of primary care across 99 UK practices identified modifiable
predictors of healthcare professionals’ prescribing, advising and foot examination.
Our objective was to evaluate the effectiveness of an implementation intervention to improve six guideline-
recommended health professional behaviours in managing type 2 diabetes in primary care: prescribing for blood
pressure and glycaemic control, providing physical activity and nutrition advice and providing updated diabetes
education and foot examination.
Methods: Two-armed cluster randomised trial involving 44 general practices. Primary outcomes (at 12 months
follow-up): from electronic medical records, the proportion of patients receiving additional prescriptions for blood
pressure and insulin initiation for glycaemic control and having a foot examination; and from a patient survey of a
random sample of 100 patients per practice, reported receipt of updated diabetes education and physical activity
and nutrition advice.
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Results: The implementation intervention did not lead to statistically significant improvement on any of the six clinical
behaviours. 1,138,105 prescriptions were assessed. Intervention (29% to 37% patients) and control arms (31% to 35%)
increased insulin initiation relative to baseline but were not statistically significantly different at follow-up (IRR 1.18,
95%CI 0.95–1.48). Intervention (45% to 53%) and control practices (45% to 50%) increased blood pressure prescription
from baseline to follow-up but were not statistically significantly different at follow-up (IRR 1.05, 95%CI 0.96 to 1.16).
Intervention (75 to 78%) and control practices (74 to 79%) increased foot examination relative to baseline; control
practices increased statistically significantly more (OR 0.84, 95%CI 0.75–0.94). Fewer patients in intervention (33%) than
control practices (40%) reported receiving updated diabetes education (OR = 0.74, 95%CI 0.57–0.97). No statistically
significant differences were observed in patient reports of having had a discussion about nutrition (intervention = 73%;
control = 72%; OR = 0.98, 95%CI 0.59–1.64) or physical activity (intervention = 57%; control = 62%; OR = 0.79, 95%CI 0.
56–1.11). Development and delivery of the intervention cost £1191 per practice.
Conclusions: There was no measurable benefit to practices’ participation in this intervention. Despite widespread use
of outreach interventions worldwide, there is a need to better understand which techniques at which intensity are
optimally suited to address the multiple clinical behaviours involved in improving care for type 2 diabetes.
Trial registration: ISRCTN, ISRCTN66498413. Registered April 4, 2013
Keywords: Diabetes, Health care professional, Behaviour change, Primary care, Cluster randomized trial, Blood pressure,
HbA1c, Lifestyle advice, Foot examination, Theory, Multiple behaviours,
Background
The estimated global prevalence of diabetes stands at 8.
5% of adults, with resulting healthcare expenditures re-
quired to support patients and populations in managing
avoidable diabetes-related morbidity [1]. Type 2 diabetes
is managed in primary care in many jurisdictions, in-
cluding the North East of England, which has a 6% esti-
mated prevalence [2]. There are widely agreed clinical
guidelines highlighting best practice and target-based in-
centive schemes promoting high-quality healthcare [3,
4]. While some data from the Quality and Outcomes
Framework (QOF, the UK’s target-based incentive pro-
gram) suggest diabetes care is improving, the most de-
manding indicators show room for improvement (e.g.
blood pressure and glycaemic control [5]). National dia-
betes audits also suggest that people with diabetes are
not receiving optimal healthcare: under 50% receive nine
key aspects of care, with variation nationwide [6]. There
remains an imperative to support healthcare profes-
sionals in improving quality of care to support patients
in achieving optimal health outcomes.
We previously conducted a UK-wide study of 99 general
practices in the UK MRC GP Research Network about their
provision of care for type 2 diabetes, identifying opportun-
ities for improvement (iQuaD study [7]). Patient records
were audited, and those with type 2 diabetes with a
guideline-defined clinical indication for increased medica-
tion for glycaemic control and hypertension were assessed
for medication alteration in the previous 25 months. Only
39.5% (1595/4038; 81 practices) and 58.9% (624/1059; 81
practices) of eligible patients were prescribed additional
therapy for hypertension and glycaemic control, respectively.
Of 29,362 patient records assessed across 86 practices, 77.
1% had a foot examination. In a patient survey assessing re-
call of care received over the past year involving 3591 pa-
tients with type 2 diabetes, 94% reported attending their
practice in the last year [8]. Only 51% of those with a BMI
over 30 reported receiving weight management advice, 68%
reported receiving self-management advice, and 73% re-
ported receiving information about diabetes [7, 8].
Many factors contribute to variations in care (e.g. pa-
tient physiology, treatment response and preferences of
patients and their families). However, it is also a function
of barriers and enablers to healthcare professional be-
haviour that, if addressed, could optimize care. iQuaD
identified modifiable determinants of clinical behaviours
that predicted subsequent behaviour [7–12]. Practice
structures of care and views about organization and
team function were not strong predictors of care. How-
ever, factors including motivation, self-efficacy, action
and coping planning and habit were consistently predict-
ive of the six clinical behaviours, providing a basis for
intervention development.
Reviews of trials of quality improvement interventions
for diabetes care show they can be effective [13]. However,
there is wide variability in effects and little understanding
of what explains such variability or the theoretical and
conceptual rationale for selecting intervention strategies
[13–15] in ways that add to those already in place (e.g.
QOF).
Many quality improvement interventions focus on a sin-
gle healthcare professional behaviour. However, clinicians
advise, assess, test, review, counsel, measure, prescribe
and refer all in time-limited consultations [16, 17]. We
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developed a multiple behaviour change intervention
aimed at primary care health professionals to improve
their management of type 2 diabetes and evaluated it in a
cluster randomized controlled trial to minimize contamin-
ation. We hypothesized that more patients with type 2
diabetes in practices receiving the intervention would re-
ceive guideline-consistent prescribing, advice and foot
examination than those in control practices.
Methods
Trial design
As described in the trial protocol [18], we conducted a
two-armed cluster randomized controlled trial. The pri-
mary care practice was the unit of randomization. The
intervention was delivered to the primary care team,
aiming to improve care provided by primary care health
professionals.
Sample size
The trial was powered to detect differences between
intervention and control practices in the six clinical be-
haviours, anticipating an intra-cluster correlation coeffi-
cient of 0.06. Sample size estimation showed that 20
patients from 40 practices were required to detect a 15%
absolute improvement in any of our six clinical behav-
iours with 80% power at 5% significance levels. To pro-
tect against cluster-level attrition, we aimed to recruit 44
practices, providing 83.9% power to detect a 15% im-
provement if all practices were retained.
Participants
General practice (clusters) recruitment and data collection
General practices in North-East England and the general
medical practitioners (GPs), nurses and healthcare assis-
tants within them involved in providing care for type 2
diabetes participated. We excluded one practice involved
in feasibility piloting. We aimed to recruit 44 practices
across North-East England. Initial recruitment and con-
tact was via research facilitators. The trial team also pre-
sented at a GP research forum. Interested practices
contacted us, and we obtained written practice-level
consent. We conducted phone interviews with practice
contacts to assess organizational structures and identify
staff involved in diabetes care. Practices randomized to
the intervention were reimbursed for staff time to pre-
pare for and attend the intervention session at an hourly
staff rate.
Healthcare professional recruitment and data collection
Consent was sought from the cluster level and the gen-
eral practice staff level prior to randomization. An infor-
mation and consent sheet was mailed to identified GPs,
nurses and healthcare assistants in each practice. We did
not involve community nurses working with multiple
practices to reduce contamination risk between inter-
vention and control practices. As part of a planned
process evaluation, a baseline and 12-month follow-up
questionnaire was posted to GPs, nurses and healthcare
assistants in all practices.
Trial patients recruitment and data collection
We included patients 18 and older with type 2 diabetes
registered in each practice. Patients were identified in
computerized medical records using diabetes-identifying
codes. We excluded patients under 18, with type 1 dia-
betes, or for whom inclusion was clinically inappropriate
as judged by each primary care team.
Intervention description
Intervention development was consistent with the UK
MRC framework for complex interventions [19] and
informed by our national study of diabetes care (iQuaD
[7]). We used behaviour change theory results from
iQuaD to identify factors to target and included
behaviour change techniques (BCTs) specified within
these theories (Social Cognitive Theory, Health Action
Process Approach, Dual Process Model, theory-based
approaches to multiple goal pursuit) [16, 20]. The over-
arching strategy involved outreach visits [21] that moved
beyond a knowledge and education-based approach that
is more common of such interventions and instead em-
phasized healthcare professional behaviour change and
addressed clinical inertia. In brief, the intervention con-
sisted of a content expert (nurse or MD) and a behav-
iour change expert delivering the intervention at each of
22 individual practices. The intervention allowed prac-
tice team members to dedicate 90 min together to con-
sider each of the targeted clinical behaviors and select
the behaviors consistent with their current role in the
practice. They considered discrepancies between per-
sonal estimates of current performance and intended
levels and identified barriers and problem solved by de-
veloping if-then plans to circumvent identified barriers.
They were provided with materials developed with pa-
tients with diabetes to pre-identify barriers and solutions
to assist in providing physical activity and healthy eating
support [22–24]. We produced short videos using trained
actors presenting practice-based examples of interactions
between patients and clinicians (available upon request),
common barriers to initiating insulin and providing phys-
ical activity advice and possible solutions for successfully
managing barriers (see online Additional files 1, 2 and 3
for detailed intervention description).
Feasibility
We conducted two feasibility tests in primary care set-
tings. The first was delivered to medical students to
assess pace and timing and identify misunderstandings.
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The second involved two GPs, two nurses and a health-
care assistant at one practice (excluded from trial
recruitment).
Control practices
Control practices supported outcome measure collection
(patient survey at 12 months follow-up and access to
anonymised patient records at 12 months follow-up); no
intervention was provided. Clinicians in control prac-
tices completed questionnaires at baseline and 12-month
follow-up (planned secondary analysis). We sent mate-
rials to control practices at the end of the trial.
Primary outcomes: six clinical behaviours
Primary outcomes were pre-specified in the protocol
[18] and consistent with the UK NICE diabetes quality
standards [4] (detailed outcome description in online
Additional file 4). Outcome data were collected
12 months after intervention delivery. For the two pre-
scribing behaviours and foot examination, outcome data
were extracted from anonymised patient electronic re-
cords for all patients meeting inclusion criteria in each
practice for 12 months before and 12 months after the
intervention period. While data on prescribing and foot
examination were available in routinely collected data in
patient electronic records, providing advice and updated
diabetes education was known to not consistently be re-
corded in medical records [7]. Outcome data on providing
advice on nutrition and physical activity and providing
updated diabetes education were therefore collected from
anonymized postal survey responses from a random sam-
ple of 100 patients with type 2 diabetes in each practice at
12 months follow-up; no pre-intervention data were col-
lected for outcomes assessed with patient surveys. Patients
reported whether they had received physical activity
advice, nutrition advice and updated diabetes education in
the preceding 12 months. We developed patient surveys
based on our previous study [7] and pilot-tested the sur-
veys with our local Diabetes UK patient group. Practices
managed processes relating to patient identification and
questionnaire mailing to maintain patient anonymity to
the trial team. One reminder was sent. Completed ques-
tionnaires were returned to the trial team with practice ID
as the only identifier.
Randomization, allocation and concealment
Practices were randomized 1:1 to intervention or control
by the trial statistician using computer-generated ran-
dom permuted blocks with practice roster (list) size as
the blocking factor. The study research associate en-
rolled the clusters (practices). Baseline data collection
(interviews and questionnaires) was completed before
practices were made aware of their allocation. The study
research associate assigned a unique study ID to each
practice, and then, the trial statistician undertook the
randomization of these IDs. The statistician and all trial
team members except the trial research associate
remained blind to practice allocation until the trial stat-
istician completed the outcome analyses.
For prescribing behaviours and foot examination, an
independent outcome assessor extracted data on health-
care professional behaviours using computerized medical
records and remained blind to allocation. Clinical behav-
iour outcomes assessed using patient surveys of care re-
ceived involved administrative staff in each practice.
This data collection occurred 12 months after the inter-
vention was delivered, at which point it is likely that ad-
ministrative staff were aware of the allocation of their
practice. Patients were not aware of the allocation.
Analysis
We treated all six outcomes equivalently and hypothe-
sized that each would show improvement in the inter-
vention arm compared with control. To protect against
type 1 error, our protocol pre-specified that the inter-
vention should show a benefit on at least two behaviours
to be regarded effective. We used different modelling
approaches depending on characteristics of the data.
Prescribing for blood pressure and prescribing insulin for
glycaemic control
The number of patients prescribed was analyzed using sep-
arate Poisson regression models. The number of patients
who met target for triggering insulin initiation and add-
itional prescribing for blood pressure post-intervention was
included as an exposure variable. Baseline performance
(proportion of patients meeting target threshold in the
6 months leading up to the intervention) and practice size
were included as covariates. The impact of the intervention
(randomization group) was included as a fixed effect.
Examining feet
The proportion of patients having their feet examined
was analysed using a mixed effects logistic regression
model. Fixed effects included the data time period (be-
fore or after the intervention) and the randomization
group. Random effects took into account that patients
were nested in practices. Additionally, an interaction
between time period and group was included to test the
effectiveness of the intervention.
Providing advice and education
We fitted a multilevel logistic model with patients
nested within practices for each of the three clinical
behaviour outcomes assessed by patient questionnaire at
12 months. As pre-specified, all analyses adjusted for
any difference between practices in terms of list (ros-
ter) size.
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Cost analysis
We compared intervention and control practices on
total prescription costs for diabetes and hypertension
medication, costs of diabetes-related health service use,
and intervention-associated costs. Prescription costs
were collected for each practice for 12 months pre- and
12 months post-intervention. We extracted data on
medication name, size, dose and prescription date for all
eligible patients included in the trial analyses of the pri-
mary outcomes. Diabetes and blood pressure medication
costs were extracted from anonymised patient medical
records in all 44 practices, consisting of 1,138,105 re-
corded prescriptions between 18 August 2012 and 28
February 2015. The total cost of prescriptions for dia-
betes and hypertension was calculated using the pre-
scription length and cost of the medication. Medication
costs were taken from the British National Formulary
archive [25] and were deflated to 2012–2013 prices and
assumed the same rate of inflation for 2015 [26]. Service
use and referral costs were calculated from patient ques-
tionnaire responses using costs data from the Unit Costs
of Healthcare [27] and NHS reference costs [28] and de-
flated to 2012–2013 prices. Post-intervention service use
costs were calculated as the post-intervention equiva-
lized total cost per patient for each practice. This pro-
vides a cost per patient for each practice, accounting for
practice size. Patients in each practice were allocated a
mean cost for their practice. The intervention costs were
provided for all intervention practices.
Results
Recruitment
We recruited 44 practices from March 2013 to Novem-
ber 2013 and randomized 22 to the intervention (153
GPs, nurses, and HCAs) and 22 (172 GPs, nurses, and
HCAs) to the control. Table 1 describes characteristics
of the practices recruited, and Fig. 1 presents the CON-
SORT flow diagram. The intervention was delivered to
each of the 22 practices in the intervention arm. One
hundred twenty-three (80.4%) GPs, nurses and health-
care assistants were present at the intervention sessions.
Seventeen other members of the practices also attended
interventions sessions, including medical students on
placement and administrative staff.
Outcome data collection
Anonymised patient records
We extracted anonymised prescribing data from 1,138,105
prescriptions across 44 practices between December 2014
and March 2015.
Patient survey
Four thousand eight-five (2110 intervention; 1975 con-
trol) patients were sent questionnaires from 42 practices.
Two practices in the control condition were not able to
send questionnaires in time for the outcome analysis;
these practices were not included in the analyses based
on patient questionnaire responses but are included in
the analyses involving prescribing and foot examination.
Two thousand ninety-seven (51.3%) patients returned a
completed questionnaire (1124 intervention [53.3%]; 973
control [49.3%]).
Primary trial outcome results
No statistically significant benefit of the intervention was
detected on any of the six healthcare professional behav-
iours targeted by the intervention (see Tables 2 and 3).
Prescribing and foot examination (patient medical records)
Both intervention (29 to 37% of eligible patients pre-
scribed) and control arms (31 to 35%) showed increased
insulin initiation in eligible patients relative to baseline
but were not significantly different from each other at
follow-up (incidence rate ratio 1.18, 95% CI 0.95 to 1.48,
p = 0.13). Similarly, both intervention (45 to 53%) and
control practices (45 to 50%) increased prescription for
blood pressure but were not significantly different from
each other at 12 months follow-up (IRR 1.05, 95% CI 0.
96 to 1.16, p = 0.29). Both intervention (75 to 78%) and
control practices (74 to 79%) increased foot examination
relative to baseline levels, with control practices increas-
ing statistically significantly more (OR 0.84, 95% CI 0.75
to 0.94, p < 0.01).
Patient-reported provision of lifestyle advice and diabetes
education (at 12 months)
A statistically significantly lower percentage of patients
in intervention practices (33%) than control practices
(40%) reported receiving updated diabetes advice (OR =
0.74, 95% CI 0.57 to 0.97, p = 0.03) at 12-months follow-
Table 1 Baseline characteristics of general practices randomized
to receive the intervention or not. Figures are means across
practices (standard deviations)
Intervention
(n = 22)
Control
(n = 22)
Number of urban practices 11 14
Number of semi-rural practices 5 5
Number of rural practices 6 3
Number of dispensing practices 7 5
Number of training practices 16 18
Mean list (roster) size at baseline (SD) 7031 (3698) 7113 (4189)
% of patients > 65 years old (SD) 20.50% (5.8) 18.22% (7.1)
% of patients with T2 diabetes (mean, SD) 4.73 (0.77) 4.77 (1.11)
Number of GPs (SD) 3.59 (2.22) 3.95 (2.98)
Number of nurses (SD) 1.92 (1.00) 1.89 (1.03)
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up. Intervention and control practices did not differ in
patient reports of having had a discussion about nutri-
tion (intervention = 73%; control = 72%; OR = 0.98, 95%
CI 0.59 to 1.64, p = 0.95) or physical activity (interven-
tion = 57%; control = 62%; OR = 0.79, 95% CI 0.56 to 1.
11, p = 0.17).
Cost analysis
Mean pre-intervention per patient prescription costs for
injectable medication to manage glycaemic control was
£6531 (95%CI £6237 to £6824) in intervention and
£7205 (95%CI £6911 to £7499) in control practices.
Costs fell to £6081 (95%CI £5806 to £6357) in interven-
tion practices and £6570 (95%CI £6313 to £6827) in
control practices post-intervention. Post-intervention
log-transformed costs per patient did not differ between
groups (p = 0.25). Blood pressure prescription costs also
fell post-intervention, from £96 (95%CI £92 to £99) and
£89 (95%CI £83 to £94) in intervention and control to
£92 (£95%CI £89 to £96) and £84 (95%CI £78 to £88)
respectively. Patient-reported service usage costs are
based on responses from 2011 people with diabetes from
20 intervention (n = 1039) and 20 control (n = 972) prac-
tices; two control practices did not return patient ques-
tionnaires, and thus, two intervention practices of similar
size were randomly removed from the data. Service use
costs were significantly higher (p < .001) in intervention
practices (mean = £24.46 per patient, 95%CI £23.90–£25.
03) compared to control practices post-intervention
(mean = £21.61 per patient, 95%CI £20.92 to £22.31),
although the absolute difference of £2.85 in costs per
patient is relatively small. The intervention cost £1191 per
Fig. 1 IDEA trial—CONSORT flow diagram
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practice for the research team to develop and deliver (see
online Additional file 5).
Discussion
Statement of principal findings
Primary care practices receiving the intervention did not
demonstrate significantly better performance on any
targeted guideline-recommended clinical behaviours
relative to control practices . For prescribing behaviours
and foot examination, intervention and control arms im-
proved at 12 months relative to baseline, but this cannot
be attributed to the intervention. Foot examination rates
were statistically significantly higher at follow-up in con-
trol (79%) compared to intervention practices (78%)
when controlling for baseline, as were patient-reported
levels of updated diabetes education (40% of patients in
control practices and 33% in intervention practices). Pre-
scription costs were not significantly different in patients
in intervention practices relative to control practices (see
Additional file 6 for CONSORT checklist).
Strengths and weaknesses of the study
Strengths include strong recruitment and retention of
practices and healthcare professionals, outcome data
collection from routinely collected data in electronic
records and patient-reported outcomes and a robust
intervention development process informed by substan-
tial prior empirical research and behaviour change the-
ory, interdisciplinary content development, intervention
delivered by content and behaviour change experts and
feasibility testing.
Patient-reported outcomes have some limitations.
First, recall-based measures are inherently limited by
recall bias, though bias will be balanced across arms.
Second, two control practices did not send patient ques-
tionnaires. Third, to maintain anonymity, practices were
responsible for selecting a random sample of patients to
whom to send questionnaires, potentially introducing
selection bias. Fourth, the 51% response rate for the
patient survey may suggest response bias; responding
patients may have presented their healthcare providers
more favourably, but this would be balanced across arms.
A lower proportion of control patients (49%) returned a
questionnaire than intervention (53%), though there is
little reason to suspect their awareness of the intervention.
Finally, as we only had post-intervention data for patient-
reported outcomes, these analyses do not account for
baseline.
The main behaviour change technique targeting self-
efficacy was ‘demonstration of the behaviour’, involving a
video presenting a primary care clinician successfully
performing the behaviour with a patient despite barriers.
Table 2 Results of prescribing for HbA1c, prescribing for blood pressure and examining feet based on patient electronic records in
intervention (n = 22) and control (n = 22) practices
Baseline Follow-up (12 months)
Outcome (clinician behaviour) Intervention Control Intervention Control Effect size (95%CI) p ICC
Prescribed additional therapy
for glycemic control1
29% 31% 37% 35% IRR 1.18 (0.95 to 1.48) 0.13 –
(95%CI 21–36%) (95%CI 22–41%) (95%CI 31–43%) (95%CI 29–41%)
Prescribed additional therapy
for blood pressure2
45% 45% 53% 50% IRR 1.05 (0.96 to 1.16) 0.29 –
(95%CI 37–52%) (95%CI 42–47%) (95%CI 47–59%) (95%CI 46–53%)
Examined circulation and
sensation in feet3
75% 74% 78% 79% OR 0.84 (0.75 to 0.94) < 0.01 0.03
Note: Percentages based on uncorrected means. Effect sizes adjusted for baseline and practice size. ICC not calculated for prescribing as unit of analysis was the
practice level
IRR incidence rate ratio, OR odds ratio, ICC intracluster correlation
1Numerator: number of patients prescribed insulin for the first time. Denominator: Number of patients with type 2 diabetes in each practice with an HbA1c
measure exceeding 58 mmol/mol (7.5%) at least once in the 12 months post-intervention who were also on three or more oral hypoglycemic drugs
2Numerator: number of patients prescribed an additional antihypertensive drug or had tablet size changed. Denominator: patients with type 2 diabetes in each
practice with at least one blood pressure measure above 140/80 mmHg, excluding those with a subsequent follow-up measure below blood pressure threshold
3Numerator: patients with recorded examination of sensation and circulation in each foot. Denominator: all patients meeting inclusion criteria
Table 3 Results of providing nutrition advice, providing on-going diabetes education and providing physical activity advice, based
on patient report at 12 months
Mean at 12 months follow-up
Outcome Intervention (n = 22) Control (n = 20) OR (95%CI) p ICC
Provide personalized nutrition advice to those with BMI > 30 73% (n = 315) 72% (n = 302) 0.98 (0.59 to 1.64) 0.95 0.11
Provide on-going diabetes education 33% (n = 326) 40% (n = 330) 0.74 (0.57 to 0.97) 0.03 0.03
Provide personalized physical activity advice 57% (n = 568) 62% (n = 522) 0.79 (0.56 to 1.11) 0.17 0.06
Reported OR adjusted for practice size
OR odds ratio, ICC intracluster correlation
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Due to time constraints, this was developed and pre-
sented only for prescribing for HbA1c and providing
physical activity advice. The assumption that effects
would generalize to the other behaviours was likely in-
sufficient. Video coverage across all behaviours and
more active techniques for building self-efficacy were
planned, but feasibility testing showed it not to be feas-
ible within 90 min. Such limitations exemplify trade-offs
between desirable and logistically possible intervention
content in this setting.
Strengths and weaknesses in relation to other studies
Primary care-based diabetes management requires mul-
tiple clinical behaviours to optimize health outcomes.
Delivering interventions which bundle behaviours re-
flects the realities of primary care [16]. Indeed, trials of
quality improvement interventions often target multiple
behaviours, such as multiple drug prescriptions and pro-
cesses of care targets. As some such interventions are ef-
fective and others not, it does not seem that the number
of target behaviours is necessarily an explanation for the
lack of effect. Interventions in other settings suggest that
targeting two behaviours concurrently is as effective as
targeting them in sequence [17, 29]. However, there may
be an inverse U-shaped curve where targeting an in-
creasing number of behaviours may be beneficial only to
a point [30]. Targeting multiple behaviours concurrently
is practical and ensures optimal use of time. Future in-
terventions should investigate whether targeting behav-
iours in parallel or in sequence is equally effective.
Mechanisms and implications
An intervention may fail to be effective for a range of
reasons [31]:
(a) Theory selection - The theoretical foundations may
be inaccurate or inappropriate: This intervention was
based on a foundation of research involving testing
organizational, team and behaviour change theory, the
latter providing consistent evidence of factors account-
ing for variability in healthcare provider behaviour,
which served as the precursor to developing the current
intervention. Future research could investigate alterna-
tive theories which may identify supplementary ap-
proaches that build on the present intervention’s
theoretical foundation. Rather than atheoretical inter-
ventions, which have a long history of scattered non-
cumulative evidence, theory provides coherence and the
capacity for developing a stronger, cumulative evidence-
base (cf [32]).
(b) Behaviour change technique selection and opera-
tionalization - techniques may be ineffective or may have
been delivered at too low intensity [33]: The techniques
in this intervention have a basis in empirical literature.
However, it seems likely that delivery intensity (one 90-
min session covering six clinical behaviours) may have
been constrained by feasibility considerations and may
have been insufficient. Interventions delivered with too
low intensity may incorrectly lead to the conclusion that
the intervention is ineffective [34];
(c) Environmental context - the context of delivery of
the intervention and care setting may conflict with pro-
posed change: Our problem solving-based intervention
allowed for inherent tailoring to the individual practice
settings. However, the intervention did not alter the
choice architecture [35] nor did the intervention change
specific environmental cues that may be supporting pre-
existing practices;
(d) Control group - may inadvertently receive an
equally effective intervention (including by contamin-
ation), and other co-occurring changes may mask inter-
vention effects [36]: The intervention was delivered in a
region active in diabetes quality improvement and fo-
cused on clinical behaviours targeted by wider-reaching
interventions (e.g. QOF). This ‘rising tide’ effect [37] was
evidenced in the three behaviours for which we have
pre- and post-data, where there was evidence that both
intervention and control practices improved relative to
baseline;
(e) Recipients targeted - may not be those delivering
sub-optimum care: Eighty percent of invited GPs,
nurses, and healthcare assistants in the intervention con-
dition attended the intervention;
(f ) Fidelity of delivery - the intervention may be poorly
delivered or delivered with low fidelity to protocol: We
assessed fidelity of delivery by coding transcribed audio
recordings of all intervention sessions and found that
the intervention was delivered with high fidelity;
(g) Evaluation time point - follow-up period may be
too long or too short to detect an effect: Given annual
review GP visits, a 12-month follow-up was the most
appropriate length of time. While possible that interven-
tion effects may have been seen earlier and tapered off,
this intervention was not of sufficient intensity for ef-
fects to last to 12 months. Our planned theory-based
process evaluation will allow us to explore some of these
possible explanations.
Unanswered questions and future research
Designing implementation interventions often involves
trade-offs between desirable (sometimes time consuming)
activities and the practical logistics of delivery in routine
general practice. Our piloting indicated that 90 min was
the maximum acceptable time that practices could fit into
schedules, and thus, the intervention was developed
within these constraints. While tempting, a longer inter-
vention or more sessions did not fit within general prac-
tice availabilities and may have undermined recruitment
and retention. It is possible that the acceptable delivery
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duration constrained the intervention to an intensity inad-
equate to produce the level of behaviour change required
to show effectiveness [34].
Trials of interventions that do not show intervention-
attributable benefit can nevertheless contribute to the
broader evidence base. Process evaluations examining
fidelity to intervention content and activation of hypoth-
esized mechanisms of action can shed light into an
otherwise black box of effects (or lack thereof ) [31, 38–
40]. Such process evaluations are planned as future
research.
Conclusions
This trial evaluated an intervention aiming to improve
six guideline recommended behaviours for type 2 dia-
betes delivered using outreach visits to primary care
teams that went well-beyond knowledge-based educa-
tional outreach and showed no evidence of its effective-
ness. As healthcare organizations continue to develop,
deliver and seek support to optimize care using outreach
visits, there is a need to better understand which tech-
niques are most effective, at what level of intensity
within available practical constraints, for improving the
multiple clinical behaviours involved in managing type 2
diabetes. Drawing on theory and evidence provides a
basis for not only one-off evaluations, but also for devel-
oping a cumulative evidence base of how to optimize
outreach-based intervention content. A commitment to
robust and iterative effectiveness evaluation of tech-
niques tested in outreach-based interventions can help
to further ensure that an evidence base can accrue to
support stakeholder decision-making.
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